Dr. Anthony Yeh is Chief Strategy Officer and Head of China business development (BD) of Biosion. He has over 15 years of broad pharmaceutical industry experience in strategy, capital market and business development.

Before Biosion, Dr. Yeh was Vice President, Head of Corporate Strategy and Capital Market at CStone Pharmaceuticals. During his 3+ years at CStone, Dr. Yeh served different leadership roles in helping to build CStone through IPO and eventually to commercialization.Before CStone, Dr. Yeh was Regional Head of Business Economics and Strategy at Abbott.Before Abbott, Dr. Yeh was engagement manager at L.E.K. Consulting where he specialized in life sciences strategy, commercial due diligence, and M&A.

Dr. Yeh holds a Ph.D. in Molecular Medicine from University of Oxford and a Bachelor of Science (honors) from Queensland University of Technology.